TYRO3
Basic information
Region (hg38): 15:41557675-41583589
Previous symbols: [ "RSE" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TYRO3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 37 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 37 | 0 | 6 |
Variants in TYRO3
This is a list of pathogenic ClinVar variants found in the TYRO3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-41561192-T-A | not specified | Uncertain significance (Jun 04, 2024) | ||
15-41561204-G-C | not specified | Uncertain significance (Sep 01, 2021) | ||
15-41561231-G-T | not specified | Uncertain significance (Sep 17, 2021) | ||
15-41561286-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
15-41561539-C-A | not specified | Uncertain significance (Feb 13, 2024) | ||
15-41562687-C-T | Benign (Apr 24, 2018) | |||
15-41564203-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
15-41564241-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
15-41564269-A-ACACTGCCTGCAGCCCCCTTCAACATCACC | 46,XX disorder of sex development | Uncertain significance (Jan 01, 2023) | ||
15-41565084-T-G | not specified | Uncertain significance (Jan 03, 2022) | ||
15-41567406-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
15-41567517-C-T | not specified | Uncertain significance (Jun 05, 2024) | ||
15-41568347-A-T | not specified | Uncertain significance (Dec 21, 2023) | ||
15-41568948-G-A | not specified | Uncertain significance (Jun 05, 2024) | ||
15-41568965-G-A | not specified | Uncertain significance (Jan 10, 2022) | ||
15-41569016-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
15-41570036-G-T | not specified | Uncertain significance (Feb 26, 2024) | ||
15-41570063-T-C | not specified | Uncertain significance (Mar 28, 2023) | ||
15-41570080-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
15-41570104-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
15-41570148-G-A | Benign (Dec 31, 2019) | |||
15-41570326-G-A | not specified | Uncertain significance (Mar 20, 2023) | ||
15-41570624-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
15-41570625-A-G | not specified | Uncertain significance (Jul 06, 2021) | ||
15-41570654-C-T | not specified | Uncertain significance (Jan 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TYRO3 | protein_coding | protein_coding | ENST00000263798 | 19 | 21664 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.33e-10 | 0.999 | 124392 | 0 | 1356 | 125748 | 0.00541 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.57 | 413 | 513 | 0.805 | 0.0000306 | 5690 |
Missense in Polyphen | 114 | 191.14 | 0.59643 | 2227 | ||
Synonymous | 0.0639 | 201 | 202 | 0.994 | 0.0000121 | 1864 |
Loss of Function | 2.93 | 22 | 42.7 | 0.516 | 0.00000213 | 461 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00642 | 0.00640 |
Ashkenazi Jewish | 0.0193 | 0.0153 |
East Asian | 0.000327 | 0.000326 |
Finnish | 0.00416 | 0.00366 |
European (Non-Finnish) | 0.00767 | 0.00665 |
Middle Eastern | 0.000327 | 0.000326 |
South Asian | 0.00479 | 0.00442 |
Other | 0.00937 | 0.00768 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including TULP1 or GAS6. Regulates many physiological processes including cell survival, migration and differentiation. Ligand binding at the cell surface induces dimerization and autophosphorylation of TYRO3 on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with PIK3R1 and thereby enhances PI3-kinase activity. Activates the AKT survival pathway, including nuclear translocation of NF-kappa-B and up-regulation of transcription of NF-kappa-B-regulated genes. TYRO3 signaling plays a role in various processes such as neuron protection from excitotoxic injury, platelet aggregation and cytoskeleton reorganization. Plays also an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response by activating STAT1, which selectively induces production of suppressors of cytokine signaling SOCS1 and SOCS3. {ECO:0000269|PubMed:20546121}.; FUNCTION: (Microbial infection) Acts as a receptor for Ebolavirus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope. {ECO:0000269|PubMed:17005688}.;
- Pathway
- Ebola Virus Pathway on Host;Ebola Virus Pathway on Host
(Consensus)
Recessive Scores
- pRec
- 0.240
Intolerance Scores
- loftool
- 0.249
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 11.98
Haploinsufficiency Scores
- pHI
- 0.266
- hipred
- Y
- hipred_score
- 0.625
- ghis
- 0.556
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.959
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tyro3
- Phenotype
- skeleton phenotype; immune system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- natural killer cell differentiation;cell adhesion;signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;neuropeptide signaling pathway;spermatogenesis;phosphatidylinositol 3-kinase signaling;Wnt signaling pathway;peptidyl-tyrosine phosphorylation;forebrain cell migration;platelet activation;secretion by cell;negative regulation of toll-like receptor signaling pathway;substrate adhesion-dependent cell spreading;ovulation cycle;apoptotic cell clearance;protein kinase B signaling;negative regulation of neuron apoptotic process;negative regulation of innate immune response;viral entry into host cell;protein autophosphorylation;negative regulation of inflammatory response;negative regulation of lymphocyte activation;vagina development;neuron cellular homeostasis;platelet aggregation
- Cellular component
- nucleus;nuclear envelope;endoplasmic reticulum membrane;integral component of plasma membrane;cell surface;receptor complex
- Molecular function
- virus receptor activity;protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase activity;protein binding;ATP binding;Wnt-protein binding;phosphatidylinositol 3-kinase binding;protein heterodimerization activity